Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1993
12/15/1993EP0573491A1 Mineralized collagen
12/15/1993EP0573479A1 Chimeric tar enzyme construction for hiv therapy
12/15/1993EP0349569B1 BOVINE INTERLEUKIN-1$g(b)
12/15/1993EP0209601B1 Recombinant colony stimulating factor-1
12/15/1993CN1079400A Anti-tumor method and anti-tumor agent
12/15/1993CA2060537A1 Msh peptide derivatives
12/14/1993US5270451 Barium sulfate, chaotropic ion, surfactant
12/14/1993US5270449 Methods for the isolation of heparin-binding brain mitogens
12/14/1993US5270326 Treatment for tissue ulceration
12/14/1993US5270302 Derivatives of tetrapeptides as CCK agonists
12/14/1993US5270301 Fluoro-amide derivatives
12/14/1993US5270300 Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone
12/14/1993US5270204 Covalent angiogenin/RNase hybrids
12/14/1993US5270202 Anti-idiotypic antibodies to human melanoma-associated proteoglycan antigen
12/14/1993US5270199 Human mannose-binding protein
12/14/1993US5270181 Peptide and protein fusions to thioredoxin and thioredoxin-like molecules
12/14/1993US5270178 Vectors and compounds for expression of zymogen forms of human protein C
12/14/1993US5270171 Cancer-associated SCM-recognition factor, preparation and method of use
12/14/1993US5270057 Salt of an organic acid
12/14/1993US5270051 Enzyme-orthokeratology
12/14/1993US5270037 Use of interferon and a substance with an antimalarial activity for the treatment of malaria infections
12/14/1993US5270031 Dentinal desensitizing compositions
12/14/1993US5270030 Fibrin binding domain polypeptide and method of producing
12/14/1993CA1325193C Class i mhc modulation of surface receptor activity
12/14/1993CA1325192C Cell-associated glucosyltransferase, an antibody thereto, and a dental caries prophylactic composition containing said antibody as an effective component
12/12/1993CA2098168A1 Hydroxamic acid derivatives
12/09/1993WO1993024660A1 Method for inhibition of viral morphogenesis
12/09/1993WO1993024649A1 Cryptosporidium polypeptides, nucleic acid, vectors and methods of use
12/09/1993WO1993024646A1 Fowl mycoplasma antigen, gene thereof, recombinant vector containing said gene, and vaccine prepared by utilizing the same
12/09/1993WO1993024643A1 Farnesyltransferase inhibitors oh-4652 and production thereof
12/09/1993WO1993024641A2 Adeno-associated virus with inverted terminal repeat sequences as promoter
12/09/1993WO1993024640A2 Methods and compositions for in vivo gene therapy
12/09/1993WO1993024635A1 Tissue plasminogen activator glycosylation variants with improved therapeutic properties
12/09/1993WO1993024627A1 Bandage for continuous application of biologicals
12/09/1993WO1993024624A1 t-PA MODIFICATION
12/09/1993WO1993024620A1 Method for obtaining ribosomal rna ribonuclease with an activity inhibiting the proteinic biosynthesis from seeds of cucumis sativus l., and utilization thereof
12/09/1993WO1993024614A1 Antibodies with specificity for multiple adhesion molecules
12/09/1993WO1993024613A1 Improved expression of human multidrug resistance genes and improved selection of cells transduced with such genes
12/09/1993WO1993024530A1 Serum amyloid a protein
12/09/1993WO1993024529A1 Retinal pigmented epithelium derived neurotrophic factor
12/09/1993WO1993024528A1 Equine herpesvirus glycoproteins
12/09/1993WO1993024527A1 Peptide inhibitors of selectin binding
12/09/1993WO1993024526A1 Peptide inhibitors of selectin binding
12/09/1993WO1993024525A1 PEPTIDES OF HUMAN p53 PROTEIN FOR USE IN HUMAN T CELL RESPONSE INDUCING COMPOSITIONS, AND HUMAN p53 PROTEIN-SPECIFIC CYTOTOXIC T-LYMPHOCYTES
12/09/1993WO1993024524A1 Single chain peptide compounds having hemoregulatory activity
12/09/1993WO1993024523A1 Double chain peptide compounds having hemoregulatory activity
12/09/1993WO1993024522A1 Double chain peptide compounds having hemoregulatory activity
12/09/1993WO1993024521A1 Bpc peptides, their preparation and use
12/09/1993WO1993024520A1 Conformationally restrained peptide analogs as antiplatelet agents
12/09/1993WO1993024519A1 Lactam dipeptides having hle inhibiting activity
12/09/1993WO1993024513A1 Gastrointestinal defensins, cdna sequences and method for the production and use thereof
12/09/1993WO1993024448A1 Amino acid derivative and use thereof
12/09/1993WO1993024150A1 Salts of peptides with carboxy-terminated polyesters
12/09/1993WO1993024145A1 Compositions useful in diagnosis and prophylaxis of lyme disease
12/09/1993WO1993024144A1 PREPARATION FOR ACTIVATION OF NATURAL KILLER CELLS (NK-CELLS), SAID PREPARATION CONTAINING INTERFERON-α AND HISTAMINE, SEROTONIN OR SUBSTANCES WITH CORRESPONDING RECEPTOR ACTIVITY
12/09/1993WO1993024143A1 A method for using lipoprotein associated coagulation inhibitor to treat sepsis
12/09/1993WO1993024142A1 New pharmaceutical uses of krill enzymes
12/09/1993WO1993024140A1 Drug for depressing serum got and gpt activities and hepatic disease curative composition
12/09/1993WO1993024139A1 Antibiotic cryptdin peptides and methods of their use
12/09/1993WO1993024138A1 Biologically active peptides having n-terminal substitutions
12/09/1993WO1993024137A1 Anti-inflammatory agent
12/09/1993WO1993024136A1 Tumor killing effects of enterotoxins, superantigens, and related compounds
12/09/1993WO1993024135A1 Novel cytokine that binds cd30
12/09/1993WO1993024133A1 CHIMERIC tRNALYS-RIBOZYME MOLECULES
12/09/1993WO1993024096A2 Use of n-(2-(dimethylamino)ethyl)acridine-4-carboxamide and its analogues for cancer treatment
12/09/1993WO1993023997A1 Pharmaceutically acceptable fixed-dried human blood platelets
12/09/1993WO1993014750A3 Amino acids useful as inhibitors of the advanced glycosylation of proteins
12/09/1993DE4221269C1 Zubereitung zur topischen Anwendung Preparation for topical use
12/09/1993CA2306952A1 Method for removing dental plaque
12/09/1993CA2137275A1 Bandage for continuous application of biologicals
12/09/1993CA2137087A1 Biologically active peptides having n-terminal substitutions
12/09/1993CA2136860A1 Use of n-(2-(dimethylamino)ethyl)acridine-4-carboxamide and its analogues for cancer treatment
12/09/1993CA2136844A1 Peptide inhibitors of selectin binding
12/09/1993CA2136719A1 Serum amyloid a protein
12/09/1993CA2136646A1 Anti-inflammatory agent
12/09/1993CA2136624A1 Peptides of human p53 protein for use in human t cell response inducing compositions, and human p53 protein-specific cytotoxic t-lymphocytes
12/09/1993CA2136619A1 Amide derivatives
12/09/1993CA2136428A1 Peptide inhibitors of selectin binding
12/09/1993CA2135800A1 Compositions useful in diagnosis and prophylaxis of lyme disease
12/09/1993CA2135645A1 Improved expression of human multidrug resistance genes and improved selection of cells transduced with such genes
12/09/1993CA2135194A1 Gastrointestinal defensins, cdna sequences and method for the production and use thereof
12/09/1993CA2134773A1 Methods and compositions for in vivo gene therapy
12/09/1993CA2131003A1 Novel cytokine that binds cd30
12/09/1993CA2114312A1 Chimeric trnalys-ribozyme molecules
12/08/1993EP0572688A1 Peptides with organo-protective activity, the process for preparing them and their use in therapy
12/08/1993EP0572641A1 Agent for stimulating animal cell division
12/08/1993EP0572573A1 Thyroid-derived chondrocyte-stimulating factor
12/08/1993EP0572553A1 Recombinant thrombin receptor and related pharmaceuticals
12/08/1993EP0572547A1 SUBSTITUTED $g(a)-AMINOALDEHYDES AND DERIVATIVES
12/08/1993EP0572541A1 Treatment of endotoxemia
12/08/1993EP0572508A1 Nucleic acid encoding insulin receptor substrate-1 (irs-1), irs-1 protein, diseases, therapy associated with the metabolism of irs-1
12/08/1993EP0572505A1 Human platelet-derived growth factor receptors
12/08/1993EP0572478A1 A method for the diagnosis and treatment of glutamic acid decarboxylase autoantigen associated diseases
12/08/1993EP0538443A4 Methods and formulations for use in inhibiting conception and in treating benign gynecological disorders
12/08/1993EP0480983B1 Use of peroxidated lipids for the preparation of medication to be used in the treatment, by local application, of circulation deficiencies
12/08/1993EP0417129B1 Lung growth stimulatory and inhibitory factors for carcinoma tumor cells
12/08/1993EP0409858B1 Heparin-binding proteins, dna coding for them, processes for producing them as well as therapeutic preparations containing them
12/08/1993EP0267204B1 Immunopotentiation
12/08/1993EP0261224B1 Synthetic htlv-iii peptides, compositions and uses thereof
12/08/1993EP0131052B1 Method for detecting, identifying, and quantitating organisms and viruses
1 ... 2913 2914 2915 2916 2917 2918 2919 2920 2921 2922 2923 2924 2925 2926 2927 2928 2929 2930 2931 2932 2933 ... 3163